Health & Wellness Today New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.

Press releases published on June 5, 2026

Jun. 5, 2026

Pyra AI Launches Lead Seeker, an AI-Powered Prospecting Workspace for Revenue Teams

Indeterminate EIN Presswire

Jun. 5, 2026

Bibles and Badges by Steven C. Hinton Offers Hope and Healing for Servants Carrying Hidden Burdens

Indeterminate EIN Presswire

Jun. 5, 2026

eVero Selected by LifePlan and Advance Care Alliance New York to Transform Care Coordination Across New York State

Indeterminate EIN Presswire

Jun. 5, 2026

Elliston Pediatrics Becomes Elliston Health, Expanding Care Across Generations

Indeterminate EIN Presswire

Jun. 5, 2026

Cearvol Wave Earns Double Design Honor, Winning Both the MUSE Design Award and the American Good Design Award

Indeterminate EIN Presswire

Jun. 5, 2026

Simply.Coach Earns 17 G2 Summer 2026 Badges, Marking Another Year of Recognition Across Coaching and Mentoring

Indeterminate EIN Presswire

Jun. 5, 2026

OmniMD Expands AI Front Desk Platform With Audit Logging, Escalation Routing, Knowledge Base, and Performance Dashboard

Indeterminate EIN Presswire

Jun. 5, 2026

Data at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of MannKind’s Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and Use with Automated Insulin Delivery (AID) Systems

Indeterminate GlobeNewswire

Jun. 5, 2026

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Indeterminate GlobeNewswire

Jun. 5, 2026

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

Indeterminate GlobeNewswire

Jun. 5, 2026

Oban BioPharma Announces Presentation of Late-Breaking Abstract at ADA 2026 Highlighting OBT-676: A First-in-Class Small Molecule Combining Dual Amylin and Calcitonin Receptor Full Agonism (DACRA) with GLP-1, GIP and Glucagon (Triple-G) Receptor…

Indeterminate GlobeNewswire

Jun. 5, 2026

Vireo Growth Inc. Completes Acquisition of Bridgewell Agribusiness LLC and Plans to Acquire Dispensaries in Nevada and Maryland

Indeterminate GlobeNewswire

Jun. 5, 2026

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 5, 2026

Premier Health of America Announces Grant of Management Cease Trade Order

Indeterminate GlobeNewswire

Jun. 5, 2026

New data from Phase 2 ZUPREME-1 trial at the American Diabetes Association 2026 Scientific Sessions further support potential of petrelintide to redefine the weight management experience for people living with overweight and obesity

Indeterminate GlobeNewswire

Jun. 5, 2026

DBV Technologies to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Jun. 5, 2026

DBV Technologies participera à la 47ème conférence annuelle Global Healthcare organisée par Goldman Sachs

Indeterminate GlobeNewswire

Jun. 5, 2026

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 5, 2026

Banner Health appoints Dr. John Rares Almasan as senior vice president, chief AI, data and infrastructure officer

Indeterminate GlobeNewswire

Jun. 5, 2026

Voting Rights and Shares Capital of the Company

Indeterminate GlobeNewswire